Dermatoepidemiology

Barzilai, David A.; Freiman, Anatoli; Dellavalle, Robert P.; Weinstock, Martin A.; Mostow, Eliot N.

doi:10.1016/j.jaad.2004.09.019

Cited by 19 publications

(6 citation statements)

References 105 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To enhance, direct and plan future dermatology services in Australia it is essential to know the characteristics of the patient population being served 1 . Despite this, there remains a paucity of data describing the demographics of the dermatology public outpatient population that represents the majority of a dermatologist's workload.…”

Section: Introductionmentioning

confidence: 99%

Dermatology outpatient population profiling: Indigenous and non-indigenous dermatoepidemiology

Heyes

Chan

Halbert

et al. 2011

Australasian Journal of Dermatology

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Dermatology outpatient population profiling: Indigenous and non-indigenous dermatoepidemiology

Heyes

Chan

Halbert

et al. 2011

Australasian Journal of Dermatology

View full text Add to dashboard Cite

show abstract

“…The CSG aims to disseminate evidence‐based guidelines to prevent, diagnose, and treat dermatological disease. Over the last 16 years, the CSG has emerged as a vanguard of evidence‐based dermatology and dermato‐epidemiology on an international scale .…”

Section: The Cochrane Skin Group: Origins Scope and Prioritiesmentioning

confidence: 99%

The Cochrane Skin Group: a vanguard for developing and promoting evidence‐based dermatology

Reddi

Prescott

Doney

et al. 2013

J Evidence Based Medicine

View full text Add to dashboard Cite

AimThe Cochrane Skin Group (CSG) is part of the international Cochrane Collaboration (http://www.cochrane.org/). The CSG prepares, maintains and disseminates high quality evidence‐based summaries on the prevention, diagnosis and treatment of skin diseases. We present a synopsis of the history, scope and priorities of the CSG. In addition, we report outcomes of CSG reviews and critically assess clinical value.MethodsDescriptive analysis of systematic reviews published by the CSG since its inception including output, impact factor, associated methodological studies, and influence in clinical guidelines, promoting patient and public engagement and in triggering new primary research.ResultsThe CSG started in 1997, and has published 61 reviews, 34 protocols and 31 registered titles by August 2013. The CSG scope includes 1000 skin diseases; 80% of reviews cover the top ten diagnoses and 40% of reviews provide clear guidance for clinical practice. CSG reviews had an impact factor of 6.1 in 2011 which places it alongside top dermatology journals. CSG reviews are typically broad in focus and have been shown to be of better quality than non‐Cochrane reviews. They are highly cited in clinical guidelines. Several reviews have identified evidence gaps that have led to better primary research.ConclusionsThe CSG has emerged as a vanguard of evidence‐based dermatology by growing a community interested in applying best external evidence to the care of skin patients and by identifying topics for research. CSG reviews are high impact, clinically relevant and have tangibly influenced international dermatology clinical practice guidelines and new research.

show abstract

“… 8,9 Approaches for manuscripts focusing on diagnosis, screening, prognosis, and risk can be found elsewhere 8 . Numerous guides in dermatoepidemiology 10,11 and evidence‐based appraisal 3,9,12–38 are also available.…”

Section: Ebm: Overview Of Stepsmentioning

confidence: 99%

Practicing Evidence‐Based Dermatology: A Short Guide

Barzilai

Weinstock²,

Mostow³

2007

Skinmed

Self Cite

View full text Add to dashboard Cite

Evidence-based medicine (EBM) is a paradigm for systematically collecting, evaluating, and applying the best information currently available to improve patient outcomes. Effective evidence-based practice requires defining an answerable, well-built question, systematically searching for the best current evidence, and appraising that evidence for validity. Essential components of EBM also require using our clinical expertise to integrate these data with our patients' characteristics, values, and circumstances; archiving the results of our EBM search; and evaluating the efficiency and effectiveness of the EBM process. Incorporating EBM to bring the best current evidence into our field can be mastered with practice and a commitment to apply the process daily.

show abstract

Dermatoepidemiology

Cited by 19 publications

References 105 publications

Dermatology outpatient population profiling: Indigenous and non-indigenous dermatoepidemiology

Dermatology outpatient population profiling: Indigenous and non-indigenous dermatoepidemiology

The Cochrane Skin Group: a vanguard for developing and promoting evidence‐based dermatology

Practicing Evidence‐Based Dermatology: A Short Guide

Contact Info

Product

Resources

About